Exact Mass: 264.1505

Exact Mass Matches: 264.1505

Found 142 metabolites which its exact mass value is equals to given mass value 264.1505, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Subaphylline

(2Z)-N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidate

C14H20N2O3 (264.1474)


Alkaloid from Ananas comosus (pineapple). Subaphylline is found in many foods, some of which are pineapple, sweet orange, corn, and fruits. Subaphylline is found in avocado. Subaphylline is an alkaloid from Ananas comosus (pineapple). CASMI2013 Challenge_2 MS2 data; [MS1] MSJ00003 CASMI2013 Challenge_2 MS1 data; [MS2] MSJ00004

   

1,7-Diphenyl-4-hepten-3-one

InChI=1/C19H20O/c20-19(16-15-18-11-5-2-6-12-18)14-8-7-13-17-9-3-1-4-10-17/h1-6,8-12,14H,7,13,15-16H2/b14-8

C19H20O (264.1514)


1,7-Diphenyl-4-hepten-3-one is found in herbs and spices. 1,7-Diphenyl-4-hepten-3-one is isolated from rhizomes of Alpinia officinarum (lesser galangal 1,7-Diphenyl-4-hepten-3-one is a diarylheptanoid. 1,7-Diphenyl-4-hepten-3-one is a natural product found in Alpinia officinarum with data available.

   

Phenylalanylvaline

(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanoic acid

C14H20N2O3 (264.1474)


Phenylalanylvaline is a dipeptide composed of phenylalanine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Valylphenylalanine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanoic acid

C14H20N2O3 (264.1474)


Valylphenylalanine is a dipeptide composed of valine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(E,E)-1,7-Diphenyl-4,6-heptadien-3-ol

(4E,6Z)-1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


(E,E)-1,7-Diphenyl-4,6-heptadien-3-ol is found in beverages. (E,E)-1,7-Diphenyl-4,6-heptadien-3-ol is a constituent of Curcuma xanthorrhiza (Java turmeric). Constituent of Curcuma xanthorrhiza (Java turmeric). (E,E)-1,7-Diphenyl-4,6-heptadien-3-ol is found in herbs and spices, beverages, and root vegetables.

   

Hexyl glucoside

2-(hexyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C12H24O6 (264.1573)


Constituent of Citrus subspecies and apples (Malus sylvestris). Hexyl glucoside is found in malus (crab apple), pomes, and citrus. Hexyl glucoside is found in citrus. Hexyl glucoside is a constituent of Citrus species and apples (Malus sylvestris)

   

1,7-diphenyl-6-hepten-3-one

1,7-diphenyl-6-hepten-3-one

C19H20O (264.1514)


   

Vorinostat

Octanedioic acid hydroxyamide phenylamide

C14H20N2O3 (264.1474)


Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors. A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs. [Wikipedia] L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

1,4,7,10,13,16-Hexaoxacyclooctadecane

1,4,7,10,13,16-Hexaoxacyclooctadecane

C12H24O6 (264.1573)


   

5-(Cycloocten-1-yl)-5-ethyl-barbituric acid

5-(cyclooct-1-en-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione

C14H20N2O3 (264.1474)


   

N-Valylphenylalanine

2-[(2-Amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoate

C14H20N2O3 (264.1474)


   

Propacetamol

N, N-Diethylglycine 4-hydroxyacetanilide ester

C14H20N2O3 (264.1474)


N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   
   
   
   
   
   
   
   

ethyl 4-(2-methoxyphenyl)piperazine-1-carboxylate

ethyl 4-(2-methoxyphenyl)piperazine-1-carboxylate

C14H20N2O3 (264.1474)


   
   

1,7-diphenyl-5-heptene-3-one

1,7-diphenyl-5-heptene-3-one

C19H20O (264.1514)


   
   

(delta-Phenyl-butyl)-styryl-keton|(E)-1,7-diphenylhept-1-en-3-one|1,7-diphenyl-4E-hepten-3-one|1,7-Diphenyl-hept-1-en-3-on|1,7-diphenyl-hept-1-en-3-one|gamma-Oxo-alpha.eta-diphenyl-alpha-heptylen

(delta-Phenyl-butyl)-styryl-keton|(E)-1,7-diphenylhept-1-en-3-one|1,7-diphenyl-4E-hepten-3-one|1,7-Diphenyl-hept-1-en-3-on|1,7-diphenyl-hept-1-en-3-one|gamma-Oxo-alpha.eta-diphenyl-alpha-heptylen

C19H20O (264.1514)


   

12-Demethylmulticaulin

12-Demethylmulticaulin

C19H20O (264.1514)


A diterpenoid that is multicaulin in which the methoxy group at position 12 is replaced by a hydroxy group. A norabietane derivative, it is isolated from the roots of Salvia multicaulis and exhibits antitubercular activity.

   

Pentifylline

Pentifylline

C13H20N4O2 (264.1586)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AD - Purine derivatives C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

3-Isobutyryl-6,7-dihydro-2-isopropylpyrazolo[1,5-a]pyridine-6,7-diol

3-Isobutyryl-6,7-dihydro-2-isopropylpyrazolo[1,5-a]pyridine-6,7-diol

C14H20N2O3 (264.1474)


   

(E)-1,7-diphenylhept-4-en-3-one

NCGC00180658-02!(E)-1,7-diphenylhept-4-en-3-one

C19H20O (264.1514)


   

2-[(2-amino-3-methylbutanoyl)amino]-3-phenylpropanoic acid

NCGC00380373-01!2-[(2-amino-3-methylbutanoyl)amino]-3-phenylpropanoic acid

C14H20N2O3 (264.1474)


   

(2R,3R,4S,5S,6R)-2-hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol

NCGC00385855-01!(2R,3R,4S,5S,6R)-2-hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol

C12H24O6 (264.1573)


   

LID_265.1546_9.2

LID_265.1546_9.2

C14H20N2O3 (264.1474)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 803 INTERNAL_ID 803; CONFIDENCE Tentative identification: most likely structure (Level 3)

   

DAH-3-Keto-4-en

DAH-3-Keto-4-en

C19H20O (264.1514)


   

Feruloyl putrescine (isomer of 1178)

Feruloyl putrescine (isomer of 1178)

C14H20N2O3 (264.1474)


Annotation level-3

   

Feruloyl putrescine (isomer of 1173)

Feruloyl putrescine (isomer of 1173)

C14H20N2O3 (264.1474)


Annotation level-3

   

Phenylalanylvaline

Phenylalanylvaline

C14H20N2O3 (264.1474)


Annotation level-2

   

valylphenylalanine

valylphenylalanine

C14H20N2O3 (264.1474)


Annotation level-2

   

Vorinostat

N1-hydroxy-N8-phenyl-octanediamide

C14H20N2O3 (264.1474)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

2H-Indol-2-one, 1,3-dihydro-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-

2H-Indol-2-one, 1,3-dihydro-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-

C14H20N2O3 (264.1474)


   
   
   

Phe-Val

2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid

C14H20N2O3 (264.1474)


A dipeptide formed from L-phenylalanine and L-valine residues.

   

Val-phe

2-(2-amino-3-phenylpropanamido)-3-methylbutanoic acid

C14H20N2O3 (264.1474)


A dipeptide formed from L-valine and L-phenylalanine residues.

   

hexyl glucoside

2-(hexyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C12H24O6 (264.1573)


   

1,7-Diphenyl-4-hepten-3-one

(4E)-1,7-diphenylhept-4-en-3-one

C19H20O (264.1514)


   

(E,E)-1,7-Diphenyl-4,6-heptadien-3-ol

(4E,6Z)-1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


   

n-hydroxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethanimidamide

n-hydroxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethanimidamide

C13H20N4O2 (264.1586)


   

tert-Butyl 2-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-ylcarbamate

tert-Butyl 2-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-ylcarbamate

C14H20N2O3 (264.1474)


   

1H-Purine-2,6-dione,1,3-dibutyl-3,9-dihydro-

1H-Purine-2,6-dione,1,3-dibutyl-3,9-dihydro-

C13H20N4O2 (264.1586)


   

1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID

1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID

C14H20N2O3 (264.1474)


   

4-Boc-7-Hydroxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

4-Boc-7-Hydroxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

C14H20N2O3 (264.1474)


   

2-(3,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO4 (264.1533)


   

4-[2-(t-butyldimethylsilyloxy)ethyl]benzaldehyde

4-[2-(t-butyldimethylsilyloxy)ethyl]benzaldehyde

C15H24O2Si (264.1545)


   

3-[2-[Tert-butyl(dimethyl)silyl]oxyethyl]benzaldehyde

3-[2-[Tert-butyl(dimethyl)silyl]oxyethyl]benzaldehyde

C15H24O2Si (264.1545)


   

tert-butyl N-(5-methoxy-4-prop-2-enylpyridin-3-yl)carbamate

tert-butyl N-(5-methoxy-4-prop-2-enylpyridin-3-yl)carbamate

C14H20N2O3 (264.1474)


   

(2-HYDROXYBENZOYL)METHYLENETRIPHENYLPHOSPHORANE

(2-HYDROXYBENZOYL)METHYLENETRIPHENYLPHOSPHORANE

C14H20N2O3 (264.1474)


   

2,5-Dimethoxyphenylboronic acid, pinacol ester

2,5-Dimethoxyphenylboronic acid, pinacol ester

C14H21BO4 (264.1533)


   

TERT-BUTYL 5-METHOXY-3,4-DIHYDRO-1,7-NAPHTHYRIDINE-1(2H)-CARBOXYLATE

TERT-BUTYL 5-METHOXY-3,4-DIHYDRO-1,7-NAPHTHYRIDINE-1(2H)-CARBOXYLATE

C14H20N2O3 (264.1474)


   

TERT-BUTYL 6-METHOXY-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE

TERT-BUTYL 6-METHOXY-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE

C14H20N2O3 (264.1474)


   

2,4-Dimethoxyphenylboronic acid pinacol ester

2,4-Dimethoxyphenylboronic acid pinacol ester

C14H21BO4 (264.1533)


   

tert-Butyl (2-(piperidin-4-yl)ethyl)carbamate hydrochloride

tert-Butyl (2-(piperidin-4-yl)ethyl)carbamate hydrochloride

C12H25ClN2O2 (264.1604)


   

2-(2,6-dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,6-dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO4 (264.1533)


   

1-[3-(Triethoxysilyl)propyl]urea

1-[3-(Triethoxysilyl)propyl]urea

C10H24N2O4Si (264.1505)


   

nonanedioic acid,propane-1,2-diol

nonanedioic acid,propane-1,2-diol

C12H24O6 (264.1573)


   

3,3-(4-Methyl-1,3-phenylene)bis(1,1-dimethylurea)

3,3-(4-Methyl-1,3-phenylene)bis(1,1-dimethylurea)

C13H20N4O2 (264.1586)


   

(R)-4-N-BOC-2-ISOPROPYLPIPERAZINE-HCl

(R)-4-N-BOC-2-ISOPROPYLPIPERAZINE-HCl

C12H25ClN2O2 (264.1604)


   

(R)-tert-Butyl 2-propylpiperazine-1-carboxylate hydrochloride

(R)-tert-Butyl 2-propylpiperazine-1-carboxylate hydrochloride

C12H25ClN2O2 (264.1604)


   

1H-Imidazolium,1-hexyl-3-methyl-,methanesulfonate

1H-Imidazolium,1-hexyl-3-methyl-,methanesulfonate

C11H24N2O3S (264.1508)


   

1-[3-(4-nitrophenoxy)propyl]piperidine

1-[3-(4-nitrophenoxy)propyl]piperidine

C14H20N2O3 (264.1474)


   

4,6-bis(allyloxy)-N-butyl-1,3,5-triazin-2-amine

4,6-bis(allyloxy)-N-butyl-1,3,5-triazin-2-amine

C13H20N4O2 (264.1586)


   

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol

C14H21BO4 (264.1533)


   

tert-butyl N-[(4-aminocyclohexyl)methyl]carbamate,hydrochloride

tert-butyl N-[(4-aminocyclohexyl)methyl]carbamate,hydrochloride

C12H25ClN2O2 (264.1604)


   

(R)-TERT-BUTYL (1-AMINO-1-OXO-3-PHENYLPROPAN-2-YL)CARBAMATE

(R)-TERT-BUTYL (1-AMINO-1-OXO-3-PHENYLPROPAN-2-YL)CARBAMATE

C14H20N2O3 (264.1474)


   

3,6,9-triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane

3,6,9-triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane

C12H24O6 (264.1573)


   

1-Butyl-4-[(4-methoxyphenyl)ethynyl]benzene

1-Butyl-4-[(4-methoxyphenyl)ethynyl]benzene

C19H20O (264.1514)


   

4-Propyl-4-ethoxytolan

4-Propyl-4-ethoxytolan

C19H20O (264.1514)


   

2-(4-MORPHOLINYL)-PYRIDINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

2-(4-MORPHOLINYL)-PYRIDINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H20N2O3 (264.1474)


   

Carbamic acid, N-[[4-[(hydroxyimino)methyl]phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester

Carbamic acid, N-[[4-[(hydroxyimino)methyl]phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester

C14H20N2O3 (264.1474)


   

TRANS-4-(BOC-AMINO)-CYCLOHEXANEMETHANAMINE HYDROCHLORIDE

TRANS-4-(BOC-AMINO)-CYCLOHEXANEMETHANAMINE HYDROCHLORIDE

C12H25ClN2O2 (264.1604)


   

Boc-L-Phenylalanine amide

Boc-L-Phenylalanine amide

C14H20N2O3 (264.1474)


   

tert-butyl 2-cyclopropyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-7-carboxylate

tert-butyl 2-cyclopropyl-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-7-carboxylate

C13H20N4O2 (264.1586)


   

(S)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYL)PYRROLIDINE-1-CARBOXYLATE HYDROCHLORIDE

(S)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYL)PYRROLIDINE-1-CARBOXYLATE HYDROCHLORIDE

C12H25ClN2O2 (264.1604)


   

(S)-BENZYL (1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)CARBAMATE

(S)-BENZYL (1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)CARBAMATE

C14H20N2O3 (264.1474)


   

2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO4 (264.1533)


   

2-[4-(methoxymethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-[4-(methoxymethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H21BO4 (264.1533)


   

2-(4-AMINO-1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID

2-(4-AMINO-1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID

C14H20N2O3 (264.1474)


   

2-(4-AMINO-1-(4-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID

2-(4-AMINO-1-(4-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID

C14H20N2O3 (264.1474)


   

1-BOC-2-PROPYLPIPERAZINE HYDROCHLORIDE

1-BOC-2-PROPYLPIPERAZINE HYDROCHLORIDE

C12H25ClN2O2 (264.1604)


   

(R)-4-N-BOC-2-PROPYLPIPERAZINE-HCl

(R)-4-N-BOC-2-PROPYLPIPERAZINE-HCl

C12H25ClN2O2 (264.1604)


   

(S)-4-N-BOC-2-PROPYLPIPERAZINE-HCl

(S)-4-N-BOC-2-PROPYLPIPERAZINE-HCl

C12H25ClN2O2 (264.1604)


   

4-ETHYLAMINO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER-HCl

4-ETHYLAMINO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER-HCl

C12H25ClN2O2 (264.1604)


   

tert-butyl 3-propan-2-ylpiperazine-1-carboxylate,hydrochloride

tert-butyl 3-propan-2-ylpiperazine-1-carboxylate,hydrochloride

C12H25ClN2O2 (264.1604)


   

tert-butyl 3-propylpiperazine-1-carboxylate,hydrochloride

tert-butyl 3-propylpiperazine-1-carboxylate,hydrochloride

C12H25ClN2O2 (264.1604)


   

2-(2-amino-3-phenylpropanamido)-3-methylbutanoic acid

2-(2-amino-3-phenylpropanamido)-3-methylbutanoic acid

C14H20N2O3 (264.1474)


   

4-[[Diethylamino(oxo)methyl]amino]benzoic acid ethyl ester

4-[[Diethylamino(oxo)methyl]amino]benzoic acid ethyl ester

C14H20N2O3 (264.1474)


   

2-Hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol

2-Hexyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol

C12H24O6 (264.1573)


   

Propacetamol

Propacetamol

C14H20N2O3 (264.1474)


N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

53180_FLUKA

(2R,3R,4S,5S,6R)-2-hexoxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

C12H24O6 (264.1573)


   

2-[(N,N-diethylglycyl)amino]-3-methylbenzoic acid

2-[(N,N-diethylglycyl)amino]-3-methylbenzoic acid

C14H20N2O3 (264.1474)


   

Streptidine dication

Streptidine dication

C8H20N6O4+2 (264.1546)


   

L-Valyl-L-phenylalanine

L-Valyl-L-phenylalanine

C14H20N2O3 (264.1474)


   

5-(Cycloocten-1-yl)-5-ethyl-barbituric acid

5-(Cycloocten-1-yl)-5-ethyl-barbituric acid

C14H20N2O3 (264.1474)


   

4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-1,3-dihydroindol-2-one

4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]-1,3-dihydroindol-2-one

C14H20N2O3 (264.1474)


   

Phenylhexanoic acid, trimethylsilyl ester

Phenylhexanoic acid, trimethylsilyl ester

C15H24O2Si (264.1545)


   

Trimethyl[4-(2-methyl-4-oxo-2-pentyl)phenoxy]silane

Trimethyl[4-(2-methyl-4-oxo-2-pentyl)phenoxy]silane

C15H24O2Si (264.1545)


   

4-Pentylbenzoic acid trimethylsilyl ester

4-Pentylbenzoic acid trimethylsilyl ester

C15H24O2Si (264.1545)


   

streptidine(2+)

streptidine(2+)

C8H20N6O4 (264.1546)


A guanidinium ion obtained by protonation of both guanidino groups of streptidine; major species at pH 7.3.

   

18-Crown-6

1,4,7,10,13,16-Hexaoxacyclooctadecane

C12H24O6 (264.1573)


   

2-Hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol

2-Hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol

C12H24O6 (264.1573)


   

Subaphyllin

N-(4-AMINOBUTYL)-3-(4-HYDROXY-3-METHOXYPHENYL)ACRYLAMIDE

C14H20N2O3 (264.1474)


   

4-Hepten-3-one, 1,7-diphenyl-

4-Hepten-3-one, 1,7-diphenyl-

C19H20O (264.1514)


   

n-[(5s,7r,7as)-7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

n-[(5s,7r,7as)-7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

2-[(3-amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoic acid

2-[(3-amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoic acid

C14H20N2O3 (264.1474)


   

(1e)-1,7-diphenylhept-1-en-3-one

(1e)-1,7-diphenylhept-1-en-3-one

C19H20O (264.1514)


   

n-[(5r,6r,7ar)-6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

n-[(5r,6r,7ar)-6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

7,8-dimethyl-2-(1-methylethyl)phenanthren-3-ol

NA

C19H20O (264.1514)


{"Ingredient_id": "HBIN012991","Ingredient_name": "7,8-dimethyl-2-(1-methylethyl)phenanthren-3-ol","Alias": "NA","Ingredient_formula": "C19H20O","Ingredient_Smile": "CC1=C(C2=C(C=C1)C3=CC(=C(C=C3C=C2)C(C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6373","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

(4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


   

1,7-diphenylhept-5-en-3-one

1,7-diphenylhept-5-en-3-one

C19H20O (264.1514)


   

methyl (2r)-2-[(5-butylpyridin-2-yl)formamido]propanoate

methyl (2r)-2-[(5-butylpyridin-2-yl)formamido]propanoate

C14H20N2O3 (264.1474)


   

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 1-methylpyrrole-2-carboxylate

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 1-methylpyrrole-2-carboxylate

C14H20N2O3 (264.1474)


   

ficuseptamine c

ficuseptamine c

[C15H22NO3]+ (264.16)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-methylbutanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-methylbutanoic acid

C14H20N2O3 (264.1474)


   

(6e)-1,7-diphenylhept-6-en-3-one

(6e)-1,7-diphenylhept-6-en-3-one

C19H20O (264.1514)


   

(3s,4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

(3s,4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

C14H20N2O3 (264.1474)


   

n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

C14H20N2O3 (264.1474)


   

2-[n'-(2-methoxy-2-methylpropyl)ethanimidamido]benzoic acid

2-[n'-(2-methoxy-2-methylpropyl)ethanimidamido]benzoic acid

C14H20N2O3 (264.1474)


   

(3r,4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

(3r,4e,6e)-1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


   

hexyl β-d-glucopyranoside

hexyl β-d-glucopyranoside

C12H24O6 (264.1573)


   

1,7-diphenylhept-6-en-3-one

1,7-diphenylhept-6-en-3-one

C19H20O (264.1514)


   

(1r,2r,5r,7r)-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-2-yl 1-methylpyrrole-2-carboxylate

(1r,2r,5r,7r)-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-2-yl 1-methylpyrrole-2-carboxylate

C14H20N2O3 (264.1474)


   

n-(6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

n-(6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

(2s)-2-[(3-amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoic acid

(2s)-2-[(3-amino-1-hydroxy-3-methylbutylidene)amino]-3-phenylpropanoic acid

C14H20N2O3 (264.1474)


   

(2e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

(2e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid

C14H20N2O3 (264.1474)


   

n-(7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

n-(7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

1,7-diphenylhept-1-en-3-one

1,7-diphenylhept-1-en-3-one

C19H20O (264.1514)


   

1,7-diphenylhepta-4,6-dien-3-ol

1,7-diphenylhepta-4,6-dien-3-ol

C19H20O (264.1514)


   

n-[(5r,7s,7ar)-7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

n-[(5r,7s,7ar)-7-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

(5e)-1,7-diphenylhept-5-en-3-one

(5e)-1,7-diphenylhept-5-en-3-one

C19H20O (264.1514)


   

(1s,2r,3r,5r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-2-yl 1-methylpyrrole-2-carboxylate

(1s,2r,3r,5r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-2-yl 1-methylpyrrole-2-carboxylate

C14H20N2O3 (264.1474)


   

hydroxy(oxo)[2-(2,2,4,6-tetramethyl-1,3-dihydroinden-5-yl)ethoxy]azanium

hydroxy(oxo)[2-(2,2,4,6-tetramethyl-1,3-dihydroinden-5-yl)ethoxy]azanium

[C15H22NO3]+ (264.16)


   

n-[(5s,6s,7as)-6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

n-[(5s,6s,7as)-6-hydroxy-5,7a-dimethyl-1-oxo-6,7-dihydro-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

C14H20N2O3 (264.1474)


   

(2r,3r,4s,5r,6r)-2-(hexyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-(hexyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C12H24O6 (264.1573)